Global, regional, and national burdens of ischemic heart disease in the older adults aged 60–89 years: a systematic analysis for the Global Burden of Disease Study 2019

BackgroundIschemic heart disease (IHD) places a heavy burden on individual and public health. Nevertheless, comprehensive assessments of the burden of IHD in the elderly are absent. It is imperative to update the burden of IHD in older adults and predict the trends.MethodsThe absolute numbers and ag...

Full description

Saved in:
Bibliographic Details
Main Authors: Hao Zhi, Yuedong Yang, Juan Zhao, Chenhan Mao, Jianping Shen, Xindong Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2025.1443881/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850278499722461184
author Hao Zhi
Hao Zhi
Hao Zhi
Yuedong Yang
Juan Zhao
Juan Zhao
Chenhan Mao
Jianping Shen
Jianping Shen
Xindong Wang
Xindong Wang
author_facet Hao Zhi
Hao Zhi
Hao Zhi
Yuedong Yang
Juan Zhao
Juan Zhao
Chenhan Mao
Jianping Shen
Jianping Shen
Xindong Wang
Xindong Wang
author_sort Hao Zhi
collection DOAJ
description BackgroundIschemic heart disease (IHD) places a heavy burden on individual and public health. Nevertheless, comprehensive assessments of the burden of IHD in the elderly are absent. It is imperative to update the burden of IHD in older adults and predict the trends.MethodsThe absolute numbers and age-standardized rates (ASRs) of prevalence, mortality, and disability-adjusted life-years (DALYs) for IHD among people aged 60–89 years from 1990 to 2019 were analyzed based on the Global Burden of Disease Study 2019 (GBD 2019). Joinpoint regression analysis was utilized to evaluate the epidemiologic trend of IHD in the elderly from 1990 to 2019. Bayesian age-period-cohort model was used to predict the burden of IHD among the elderly from 2020 to 2034.ResultsAge-standardized prevalence rate (ASPR), age-standardized incidence rate (ASIR), age-standardized DALY rate (ASDR), and age-standardized mortality rate (ASMR) of IHD in older adults have declined slightly over the past 30 years. In 2019, the ASPR, ASIR, ASDR, and ASMR among the elderly with IHD were 14,280.53 (95% UI, 12,301.34–16,610.6), 1,445.21 (1,142–1,793.58), 11,225.74 (10,342.09–11,960.64), and 675.24 (614.21–721.75) per 100,000. The burden of IHD was significantly higher in older men than in women during the study period. In terms of socio-demographic index (SDI), countries and territories with lower SDI bore a more severe burden of IHD. The burden of IHD in the elderly varied considerably across countries. Uzbekistan had the largest increase in rates of prevalence, incidence, DALY, and mortality. The projections show a downward trend in DALY and mortality rates for IHD in older adults from 2020 to 2034, but incidence and prevalence will increase.ConclusionFrom 1990 to 2019, the worldwide burden of IHD among the elderly witnessed a decline. The IHD burden varied significantly across countries and territories. Policymakers should rationalize the allocation of health resources and implement effective prevention and treatment strategies to reduce the burden of IHD among the elderly in economically less developed countries and regions.
format Article
id doaj-art-6caf41c7a5ea4fd1bd383affa8495bef
institution OA Journals
issn 2297-055X
language English
publishDate 2025-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj-art-6caf41c7a5ea4fd1bd383affa8495bef2025-08-20T01:49:28ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2025-03-011210.3389/fcvm.2025.14438811443881Global, regional, and national burdens of ischemic heart disease in the older adults aged 60–89 years: a systematic analysis for the Global Burden of Disease Study 2019Hao Zhi0Hao Zhi1Hao Zhi2Yuedong Yang3Juan Zhao4Juan Zhao5Chenhan Mao6Jianping Shen7Jianping Shen8Xindong Wang9Xindong Wang10The Third Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, ChinaNanjing Lishui District Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, ChinaThe Third Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, ChinaThe Third Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, ChinaThe Third Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, ChinaBackgroundIschemic heart disease (IHD) places a heavy burden on individual and public health. Nevertheless, comprehensive assessments of the burden of IHD in the elderly are absent. It is imperative to update the burden of IHD in older adults and predict the trends.MethodsThe absolute numbers and age-standardized rates (ASRs) of prevalence, mortality, and disability-adjusted life-years (DALYs) for IHD among people aged 60–89 years from 1990 to 2019 were analyzed based on the Global Burden of Disease Study 2019 (GBD 2019). Joinpoint regression analysis was utilized to evaluate the epidemiologic trend of IHD in the elderly from 1990 to 2019. Bayesian age-period-cohort model was used to predict the burden of IHD among the elderly from 2020 to 2034.ResultsAge-standardized prevalence rate (ASPR), age-standardized incidence rate (ASIR), age-standardized DALY rate (ASDR), and age-standardized mortality rate (ASMR) of IHD in older adults have declined slightly over the past 30 years. In 2019, the ASPR, ASIR, ASDR, and ASMR among the elderly with IHD were 14,280.53 (95% UI, 12,301.34–16,610.6), 1,445.21 (1,142–1,793.58), 11,225.74 (10,342.09–11,960.64), and 675.24 (614.21–721.75) per 100,000. The burden of IHD was significantly higher in older men than in women during the study period. In terms of socio-demographic index (SDI), countries and territories with lower SDI bore a more severe burden of IHD. The burden of IHD in the elderly varied considerably across countries. Uzbekistan had the largest increase in rates of prevalence, incidence, DALY, and mortality. The projections show a downward trend in DALY and mortality rates for IHD in older adults from 2020 to 2034, but incidence and prevalence will increase.ConclusionFrom 1990 to 2019, the worldwide burden of IHD among the elderly witnessed a decline. The IHD burden varied significantly across countries and territories. Policymakers should rationalize the allocation of health resources and implement effective prevention and treatment strategies to reduce the burden of IHD among the elderly in economically less developed countries and regions.https://www.frontiersin.org/articles/10.3389/fcvm.2025.1443881/fullglobal burden of diseaseolder adultsischemic heart diseasedisability-adjusted life-yearmortalityprevalence
spellingShingle Hao Zhi
Hao Zhi
Hao Zhi
Yuedong Yang
Juan Zhao
Juan Zhao
Chenhan Mao
Jianping Shen
Jianping Shen
Xindong Wang
Xindong Wang
Global, regional, and national burdens of ischemic heart disease in the older adults aged 60–89 years: a systematic analysis for the Global Burden of Disease Study 2019
Frontiers in Cardiovascular Medicine
global burden of disease
older adults
ischemic heart disease
disability-adjusted life-year
mortality
prevalence
title Global, regional, and national burdens of ischemic heart disease in the older adults aged 60–89 years: a systematic analysis for the Global Burden of Disease Study 2019
title_full Global, regional, and national burdens of ischemic heart disease in the older adults aged 60–89 years: a systematic analysis for the Global Burden of Disease Study 2019
title_fullStr Global, regional, and national burdens of ischemic heart disease in the older adults aged 60–89 years: a systematic analysis for the Global Burden of Disease Study 2019
title_full_unstemmed Global, regional, and national burdens of ischemic heart disease in the older adults aged 60–89 years: a systematic analysis for the Global Burden of Disease Study 2019
title_short Global, regional, and national burdens of ischemic heart disease in the older adults aged 60–89 years: a systematic analysis for the Global Burden of Disease Study 2019
title_sort global regional and national burdens of ischemic heart disease in the older adults aged 60 89 years a systematic analysis for the global burden of disease study 2019
topic global burden of disease
older adults
ischemic heart disease
disability-adjusted life-year
mortality
prevalence
url https://www.frontiersin.org/articles/10.3389/fcvm.2025.1443881/full
work_keys_str_mv AT haozhi globalregionalandnationalburdensofischemicheartdiseaseintheolderadultsaged6089yearsasystematicanalysisfortheglobalburdenofdiseasestudy2019
AT haozhi globalregionalandnationalburdensofischemicheartdiseaseintheolderadultsaged6089yearsasystematicanalysisfortheglobalburdenofdiseasestudy2019
AT haozhi globalregionalandnationalburdensofischemicheartdiseaseintheolderadultsaged6089yearsasystematicanalysisfortheglobalburdenofdiseasestudy2019
AT yuedongyang globalregionalandnationalburdensofischemicheartdiseaseintheolderadultsaged6089yearsasystematicanalysisfortheglobalburdenofdiseasestudy2019
AT juanzhao globalregionalandnationalburdensofischemicheartdiseaseintheolderadultsaged6089yearsasystematicanalysisfortheglobalburdenofdiseasestudy2019
AT juanzhao globalregionalandnationalburdensofischemicheartdiseaseintheolderadultsaged6089yearsasystematicanalysisfortheglobalburdenofdiseasestudy2019
AT chenhanmao globalregionalandnationalburdensofischemicheartdiseaseintheolderadultsaged6089yearsasystematicanalysisfortheglobalburdenofdiseasestudy2019
AT jianpingshen globalregionalandnationalburdensofischemicheartdiseaseintheolderadultsaged6089yearsasystematicanalysisfortheglobalburdenofdiseasestudy2019
AT jianpingshen globalregionalandnationalburdensofischemicheartdiseaseintheolderadultsaged6089yearsasystematicanalysisfortheglobalburdenofdiseasestudy2019
AT xindongwang globalregionalandnationalburdensofischemicheartdiseaseintheolderadultsaged6089yearsasystematicanalysisfortheglobalburdenofdiseasestudy2019
AT xindongwang globalregionalandnationalburdensofischemicheartdiseaseintheolderadultsaged6089yearsasystematicanalysisfortheglobalburdenofdiseasestudy2019